Johnson & Johnson Finds Counterfeiting
Johnson & Johnson said an additional incident of counterfeiting involving the Procrit anemia drug has been found, the second time in a week the drug maker reported that some of the medicine was diluted.
In a letter dated Friday, the company told doctors and other health-care professionals to watch for Procrit with Lot No. P002384.
Authentic medicine with the lot number was shipped in September, and Johnson & Johnson said it was likely that all of that Procrit was used, so any product with the number would be suspect.
The Food and Drug Administration posted Johnson & Johnson’s letter about the new case on its Web site.
In a letter Thursday, the drug maker said greatly weakened Procrit had been found in Texas and urged health-care personnel to watch for Lot P002641.
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
